The methodology works. We take a look at your favorite stocks with a most widely-held update of the MANIFEST 40, how they've done over eight years and why we expect similar success from the next eight or 70 years.
You don’t have to google very long to come up with a long list of articles and commentaries about the death of “buy and hold” as a strategy.
TEVA is the largest generic drug manufacturing company in the world, and is focusing on building a stronger generic drug portfolio.
Accumulate Vanguard Technology
Every week we sort through the update batch and feature companies with solid return forecasts according to Value Line. This month, we share the results of that screen.